Test Price
3,000 AED✅ Home Collection Available
Parkinson Disease NGS Genetic Panel in UAE | 3000 AED | Comprehensive Genetic Testing
Executive Summary & Core Metrics
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139)
- ✓Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
- ✓Clinical Guidance: Genetic Counseling and Post-Test Telephone Support by Consultant Medical Genetics
- ✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The Parkinson Disease NGS Genetic Panel is a next-generation sequencing test that simultaneously analyzes multiple genes linked to hereditary Parkinson’s disease, identifying pathogenic variants with high precision.
| Feature | Our NGS Panel | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Gene Coverage | >30 genes (SNCA, LRRK2, PARK2, PINK1, DJ-1, etc.) | 1 gene at a time |
| Methodology | NGS (Illumina® platform, GRCh38 reference) | Capillary electrophoresis (Sanger) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks per gene |
| Variant Detection | SNVs, indels, CNVs (depending on panel) | SNVs and small indels only |
| Clinical Utility | Comprehensive risk profile, family screening | Limited to known single‑gene cause |
Physician Insight & Safety Protocols
"As a consultant medical geneticist, I understand the anxiety that comes with a potential hereditary condition. This NGS panel provides molecular clarity, but results must always be interpreted within the full clinical context, including family history and neurological examination. Genetic counseling is essential for decision-making."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Caution
Never cease or modify your prescribed Parkinson’s medications, such as levodopa or dopamine agonists, without explicit instruction from your treating neurologist. Genetic results alone do not warrant treatment changes.
Exclusion Criteria & Emergency Red Flags
- Active febrile illness or chemotherapy within the last 14 days (may affect DNA quality).
- Known severe coagulopathy or platelet count <50,000/µL (postpone phlebotomy).
- Inability to provide informed consent or absence of legal guardian for minors (Federal Decree-Law No. 4 of 2016 on Medical Liability).
- After sample collection: Seek emergency care for excessive bleeding, expanding hematoma, or signs of infection at puncture site.
Patient FAQ & Clinical Guidance
1. What is the Parkinson Disease NGS Genetic Panel?
This is a comprehensive next-generation sequencing test that analyzes over 30 genes associated with hereditary Parkinson’s disease, including SNCA, LRRK2, PARK2, PINK1, and DJ-1, identifying disease-causing variants. It is recommended for individuals with a family history of Parkinson’s or early-onset symptoms.
2. How accurate is the test, and what do the results mean?
The test has 99.9% analytical sensitivity and specificity. A positive result indicates a genetic risk factor, but it does not confirm a clinical diagnosis. Results must be interpreted by a neurologist and genetic counselor in context of your symptoms and family history.
3. Is a doctor’s referral required, and is genetic counseling included?
A referral is recommended but not mandatory. Genetic counseling is included as part of the service to help you understand the implications of your results and guide family screening if needed.
UAE Regulatory & Data Privacy Adherence
Our operations comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, processed securely, and used solely for diagnostic purposes with patient consent. The laboratory holds DHA Facility License No. 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | Parkinson Disease NGS Genetic Panel |
| Price (AED) | 3,000 |
| Turnaround Time | 3-4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3-5 mL EDTA) - VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (Illumina platform) |
| ICD-10-CM Code | G20 |
| LOINC Code | 83440-6 |
| DHA Facility License & Laboratory Address | DHA License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians